SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-23-002462
Filing Date
2023-07-17
Accepted
2023-07-17 08:15:08
Documents
8
Period of Report
2023-07-17

Document Format Files

Seq Description Document Type Size
1 6-K zk2329982.htm 6-K 19476
2 EXHIBIT 5.1 exhibit_5-1.htm EX-99 10145
3 EXHIBIT 10.1 exhibit_10-1.htm EX-99 200633
4 EXHIBIT 10.2 exhibit_10-2.htm EX-99 46243
5 EXHIBIT 99.1 exhibit_99-1.htm EX-99.1 16387
6 image0.jpg GRAPHIC 31515
7 image00001.jpg GRAPHIC 2995
8 image00003.jpg GRAPHIC 7158
  Complete submission text file 0001178913-23-002462.txt   351496
Mailing Address 13 GAD FEINSTEIN STREET PARK REHOVOT P.O.B 2100 REHOVOT L3 76121
Business Address 13 GAD FEINSTEIN STREET PARK REHOVOT P.O.B 2100 REHOVOT L3 76121 97289311900
Evogene Ltd. (Filer) CIK: 0001574565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36187 | Film No.: 231090572
SIC: 2870 Agricultural Chemicals